Updated Jul 16, 2026
Mhatre Rohin has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the 2026-05-18 SEC filing related to Repligen Corp, Mhatre Rohin is a person connected to the company in a capacity disclosed in the filing. Public biographical information beyond this SEC reference is not readily available, so the exact role, background, and career details are not documented in widely accessible sources. Repligen Corp is a biotechnology company that provides products and services for biopharmaceutical manufacturing and bioprocessing.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | RGEN | REPLIGEN CORP | A — Grant or award | 995 | $0.00 |
Based on the 2026-05-18 SEC filing related to Repligen Corp, Mhatre Rohin is a person connected to the company in a capacity disclosed in the filing. Public biographical information beyond this SEC reference is not readily available, so the exact role, background, and career details are not documented in widely accessible sources. Repligen Corp is a biotechnology company that p…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mhatre Rohin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.